We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Amazon Fear Grips Retail Pharmacy Space, Alliances Continue
Read MoreHide Full Article
It seems that e-commerce giant Amazon's (AMZN - Free Report) entry in the pharmacy retail market along with other non-healthcare heavyweights like Berkshire Hathaway and JPMorgan has initiated a new episode in the healthcare space. According to many market watchers, the traditional retail pharmacy and drugstore industry is set to undergo a sea change.
This development has been taken quite seriously by drugstore industry players who are unwilling to give up and lose their turf. These traditional pharmacy players are currently coming together to defend their position.
Consolidations in the Traditional Pharmaceutical and Drug Retail Space
After underperforming for a year, shares of Walgreens (WBA - Free Report) finally rallied 1.6% to close at $71.79 after the company entered into a seven-year alliance with Microsoft Corporation (MSFT - Free Report) .
The partnership will combine Microsoft Azure, Microsoft's cloud and AI platform, health care investments and new retail solutions, with Walgreen’s customer reach, convenient locations, outpatient health care services and industry expertise. According to a CNBC article, this alliance will explore digital health opportunities within stores and develop software for managing patient engagement.
While Amazon is trying to figure out ways to enter the multibillion dollar pharmacy industry, this is not the first attempt made by Walgreens to counter competition. Following Amazon’s foray into the healthcare retail industry last June (through the purchase of online pharmacy PillPack in December), Walgreens formed an alliance with Alphabet’s (GOOGL - Free Report) life sciences and healthcare segment, Verily, to collaborate on multiple projects. According to Walgreens, this strategic tie-up was designed to combine Verily’s healthcare technology innovation with Walgreens’ pharmacy services.
In this regard, we note that following Amazon’s PillPack deal, Walgreens CEO Stefano Pessina stated he was "not particularly worried" about Amazon. Walgreens currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Another established player CVS Health (CVS - Free Report) is also following Walgreens’ footstep. This Zacks Rank #1 PBM (pharmacy benefit manager) company achieved a momentous healthcare consolidation by acquiring United States’ third largest health insurer Aetna for a colossal sum of $70 billion.
Last month, prominent health insurer Cigna (CI - Free Report) merged with PBM player, Express Scripts. This latest deal can effectively drive the breadth of value-based relationships for Cigna and add to its fast-growing collaborative care network.
Summing Up
In any business, bankable human resource and strong financial position matter the most. And Amazon has both. Undoubtedly, Amazon’s entry has resulted in an upheaval in the prescription drug industry with major players struggling to keep afloat.
However, some analysts believe those preferring cash payments are expected to opt for Amazon’s pharmacy services. However, the percentage of this population is quite nominal. Moreover, patients with the need for immediate drugs will prefer buying them from stores over waiting for online delivery.
Considering these factors, major analysts believe there is enough scope left for the existing industry behemoths to maintain a competitive edge.
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.
Image: Bigstock
Amazon Fear Grips Retail Pharmacy Space, Alliances Continue
It seems that e-commerce giant Amazon's (AMZN - Free Report) entry in the pharmacy retail market along with other non-healthcare heavyweights like Berkshire Hathaway and JPMorgan has initiated a new episode in the healthcare space. According to many market watchers, the traditional retail pharmacy and drugstore industry is set to undergo a sea change.
This development has been taken quite seriously by drugstore industry players who are unwilling to give up and lose their turf. These traditional pharmacy players are currently coming together to defend their position.
Consolidations in the Traditional Pharmaceutical and Drug Retail Space
After underperforming for a year, shares of Walgreens (WBA - Free Report) finally rallied 1.6% to close at $71.79 after the company entered into a seven-year alliance with Microsoft Corporation (MSFT - Free Report) .
Walgreens Boots Alliance, Inc. Price
Walgreens Boots Alliance, Inc. Price | Walgreens Boots Alliance, Inc. Quote
The partnership will combine Microsoft Azure, Microsoft's cloud and AI platform, health care investments and new retail solutions, with Walgreen’s customer reach, convenient locations, outpatient health care services and industry expertise. According to a CNBC article, this alliance will explore digital health opportunities within stores and develop software for managing patient engagement.
While Amazon is trying to figure out ways to enter the multibillion dollar pharmacy industry, this is not the first attempt made by Walgreens to counter competition. Following Amazon’s foray into the healthcare retail industry last June (through the purchase of online pharmacy PillPack in December), Walgreens formed an alliance with Alphabet’s (GOOGL - Free Report) life sciences and healthcare segment, Verily, to collaborate on multiple projects. According to Walgreens, this strategic tie-up was designed to combine Verily’s healthcare technology innovation with Walgreens’ pharmacy services.
In this regard, we note that following Amazon’s PillPack deal, Walgreens CEO Stefano Pessina stated he was "not particularly worried" about Amazon. Walgreens currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Another established player CVS Health (CVS - Free Report) is also following Walgreens’ footstep. This Zacks Rank #1 PBM (pharmacy benefit manager) company achieved a momentous healthcare consolidation by acquiring United States’ third largest health insurer Aetna for a colossal sum of $70 billion.
CVS Health Corporation Price
CVS Health Corporation Price | CVS Health Corporation Quote
Last month, prominent health insurer Cigna (CI - Free Report) merged with PBM player, Express Scripts. This latest deal can effectively drive the breadth of value-based relationships for Cigna and add to its fast-growing collaborative care network.
Summing Up
In any business, bankable human resource and strong financial position matter the most. And Amazon has both. Undoubtedly, Amazon’s entry has resulted in an upheaval in the prescription drug industry with major players struggling to keep afloat.
However, some analysts believe those preferring cash payments are expected to opt for Amazon’s pharmacy services. However, the percentage of this population is quite nominal. Moreover, patients with the need for immediate drugs will prefer buying them from stores over waiting for online delivery.
Considering these factors, major analysts believe there is enough scope left for the existing industry behemoths to maintain a competitive edge.
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.
Click here for the 6 trades >>